These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1117 related articles for article (PubMed ID: 34499810)
61. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma. Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347 [TBL] [Abstract][Full Text] [Related]
62. Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma. Li J; Gao X; Tian S; Tang M; Liu W Future Oncol; 2021 Dec; 17(34):4745-4756. PubMed ID: 34658257 [TBL] [Abstract][Full Text] [Related]
63. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma. Niu W; Jiang L Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527 [TBL] [Abstract][Full Text] [Related]
64. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
65. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161 [TBL] [Abstract][Full Text] [Related]
66. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas. Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759 [TBL] [Abstract][Full Text] [Related]
67. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma. Wu C; Hu Q; Ma D Sci Rep; 2021 Feb; 11(1):3611. PubMed ID: 33574499 [TBL] [Abstract][Full Text] [Related]
68. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature. Si Y; Zhao Z; Meng X; Zhao K Sci Rep; 2024 Oct; 14(1):23243. PubMed ID: 39369095 [TBL] [Abstract][Full Text] [Related]
69. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. Li C; Wang X; Qin R; Zhong Z; Sun C Front Genet; 2021; 12():698040. PubMed ID: 34539737 [TBL] [Abstract][Full Text] [Related]
70. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD. Ma C; Gu Z; Yang Y J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237 [TBL] [Abstract][Full Text] [Related]
71. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391 [TBL] [Abstract][Full Text] [Related]
72. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
73. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J Front Immunol; 2022; 13():922315. PubMed ID: 35774794 [TBL] [Abstract][Full Text] [Related]
74. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
75. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
76. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma. Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q Front Immunol; 2021; 12():693062. PubMed ID: 34497605 [TBL] [Abstract][Full Text] [Related]
77. Ferroptosis-related genes DUOX1 and HSD17B11 affect tumor microenvironment and predict overall survival of lung adenocarcinoma patients. Wei C; Li L; Qiao Y; Chen Y; Zhang C; Xie J; Fang J; Liang Z; Huang D; Wu D Medicine (Baltimore); 2024 May; 103(22):e38322. PubMed ID: 39259123 [TBL] [Abstract][Full Text] [Related]
78. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma. Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344 [TBL] [Abstract][Full Text] [Related]
79. Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer. Weijiao Y; Fuchun L; Mengjie C; Xiaoqing Q; Hao L; Yuan L; Desheng Y Aging (Albany NY); 2021 Jun; 13(12):16713-16732. PubMed ID: 34170849 [TBL] [Abstract][Full Text] [Related]
80. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]